Related Experiment Video
Updated: Jul 24, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
A physical approach to coeliac disease
1Department of Physiology, University of New England, Armidale N.S.W. Australia.
Coeliac disease (CD) may result from the gastric mucosal barrier (GMB) extending to the duodenum. This barrier, composed of phospholipids, could impede nutrient absorption, with gluten exacerbating the condition.
Area of Science:
- Gastroenterology
- Cell Biology
- Biochemistry
Background:
- Coeliac disease (CD) diagnosis relies on specific morphological changes in the duodenum.
- These changes align with hypotheses of increased surface energy at the duodenal epithelium-luminal content interface.
- The gastric mucosal barrier (GMB), a hydrophobic layer of phospholipids, is known to protect the stomach.
Purpose of the Study:
- To propose and explore the hypothesis that the GMB extends to the duodenum in coeliac patients.
- To investigate the potential role of this extended barrier in nutrient absorption impairment.
- To elucidate the mechanism by which gluten/gliadin interacts with this barrier.
Main Methods:
- Conceptual hypothesis based on existing morphological and biochemical data.
- Analysis of the physical properties of the GMB and its potential function as an absorptive barrier.
- Examination of the interaction between gluten/gliadin, phospholipids, and duodenal enzymes.
Main Results:
- The hypothesis suggests that an extended GMB in the duodenum could explain observed morphological changes in CD.
- This phospholipid-based barrier may function to reduce nutrient absorption in the duodenum.
- Gluten and gliadin appear to act as carriers for phospholipids, facilitating their deposition and interaction with duodenal enzymes.
Conclusions:
- The GMB may extend to the duodenum, creating a hydrophobic barrier that impairs nutrient absorption.
- This extended barrier, exacerbated by gluten/gliadin, offers a novel perspective on coeliac disease pathogenesis.
- Further research is warranted to validate the presence and function of an extended GMB in coeliac disease.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...

